Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.

C G Peterson1, P Venge

  • 1Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

The Biochemical Journal
|August 1, 1987
PubMed
Summary

Eosinophil cationic protein (ECP) forms complexes with alpha 2-macroglobulin (alpha 2M) in human plasma. This interaction may protect the body from ECP's harmful effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients.

Minerva anestesiologica·2014
Same author

Cationic proteins of human granulocytes: Enhancement of phagocytosis ofStaphylococcus protein A-IgG complexes.

Inflammation·2013
Same author

Cationic proteins of human granulocytes Effects on human platelet aggregation and serotonin release.

Inflammation·2013
Same author

Multicenter analytical evaluation of a high-sensitivity troponin T assay.

Clinica chimica acta; international journal of clinical chemistry·2011
Same author

Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy.

Clinical nephrology·2010
Same author

Dibutoline; effect on insulin-induced gastric hypermotility in human subjects, and other observations.

Gastroenterology·2010

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • Eosinophil cationic protein (ECP) is a highly basic and cytotoxic protein.
  • ECP plays a role in inflammatory responses and can cause tissue damage.
  • Understanding ECP's interactions with plasma proteins is crucial for its regulation.

Purpose of the Study:

  • To investigate the interaction between ECP and human plasma proteins.
  • To identify the major plasma protein that forms complexes with ECP.
  • To elucidate the mechanisms and conditions influencing ECP-plasma protein complex formation.

Main Methods:

  • Complex formation assays using purified ECP and human plasma/serum.
  • Analysis of ECP-alpha 2-macroglobulin (alpha 2M) complexes.

Related Experiment Videos

  • Investigation of factors influencing binding, including methylamine and proteinases (cathepsin G, thrombin).
  • Assessment of the nature of the ECP-alpha 2M interaction (covalent vs. non-covalent).

    • Main Results:

    • The primary plasma protein interacting with ECP is the 'fast' form of alpha 2-macroglobulin (alpha 2M).
    • Elevated ECP-alpha 2M complexes were observed in hypereosinophilic syndrome serum.
    • Complex formation was enhanced by methylamine and proteinases like cathepsin G and thrombin, suggesting a shared binding mechanism.
    • The ECP-alpha 2M interaction is non-covalent but stable under high salt conditions.

    Conclusions:

    • Alpha 2-macroglobulin is the major binding protein for ECP in human plasma.
    • The formation of ECP-alpha 2M complexes may represent a protective mechanism against ECP-induced cytotoxicity.
    • The binding is influenced by conformational changes in alpha 2M induced by various agents.